Literature DB >> 2993412

The effects of vasoactive intestinal peptide on human natural killer cell function.

M Rola-Pleszczynski, D Bolduc, S St-Pierre.   

Abstract

Vasoactive intestinal peptide (VIP) can be found at nerve endings in various tissues and has recently been shown to interact with human lymphocytes through an adenylate cyclase-linked receptor. Because various neuroendocrine factors are thought to influence immune responsiveness, we studied the effect of VIP on natural killer (NK) effector function. Human lymphocytes were incubated with 51Cr-labeled K562 target cells in a 4-hr cytotoxicity assay in the absence or presence of increasing concentrations of VIP. As expected from its activation of adenylate cyclase, VIP was inhibitory at 10(-6) to 10(-10) M. Interestingly, however, when lymphocytes were preincubated with VIP for 30 or 60 min, then washed and added to target cells, a significant augmentation of NK activity ensued. Binding studies revealed that preincubation with VIP resulted in increased numbers of effector-target conjugates, whereas cytotoxic activity in agarose was not affected at the single cell level. Studies with synthetic analogs of VIP revealed that the integrity of the 14-28 C-terminal amino acid sequence was essential for its activity in cytotoxicity. These data strongly suggest a functional role for VIP in modulating immune responses during neuroendocrine interactions with the immune system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993412

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells.

Authors:  C Ishioka; A Yoshida; H Kimata; H Mikawa
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

2.  Predominant expression of type II vasoactive intestinal peptide receptors by human T lymphoblastoma cells: transduction of both Ca2+ and cyclic AMP signals.

Authors:  M Xia; S P Sreedharan; E J Goetzl
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

Review 3.  Vasoactive intestinal peptide.

Authors:  S I Said
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

4.  Selective modulation of the natural killer activity of murine intestinal intraepithelial leucocytes by the neuropeptide substance P.

Authors:  K Croitoru; P B Ernst; J Bienenstock; I Padol; A M Stanisz
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

5.  Human intraepithelial lymphocytes. Immunomodulation and receptor binding of vasoactive intestinal peptide.

Authors:  A I Roberts; A Panja; R E Brolin; E C Ebert
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

6.  Vasoactive intestinal peptide induces S(alpha)/S(mu) switch circular DNA in human B cells.

Authors:  S Fujieda; J A Waschek; K Zhang; A Saxon
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

Review 7.  Neuroendocrine modulation of the immune system. Possible implications for inflammatory bowel disease.

Authors:  F Shanahan; P Anton
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

Review 8.  Anti-migraine agents from an immunological point of view.

Authors:  Bakri M Assas
Journal:  J Transl Med       Date:  2021-01-06       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.